Canadian Research Group in Immuno-Oncology
Canadian Research Group in Immuno-Oncology
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis | arthritic joint disease, arthropathy, musculoskeletal system disorder | Recruiting | Phase 2 | 2026-03-03 | NCT06037811 |